Wang, S., Zhang, X., Han, T., Xie, W., Li, Y., Ma, H., . . . Ding, H. (2018, September). Tolvaptan treatment improves survival of cirrhotic patients with ascites and hyponatremia. BMC Gastroenterology.
Chicago Style (17th ed.) CitationWang, Shuzhen, Xin Zhang, Tao Han, Wen Xie, Yonggang Li, Hong Ma, Roman Liebe, Honglei Weng, and Hui-Guo Ding. "Tolvaptan Treatment Improves Survival of Cirrhotic Patients with Ascites and Hyponatremia." BMC Gastroenterology Sep. 2018.
MLA (9th ed.) CitationWang, Shuzhen, et al. "Tolvaptan Treatment Improves Survival of Cirrhotic Patients with Ascites and Hyponatremia." BMC Gastroenterology, Sep. 2018.
Warning: These citations may not always be 100% accurate.
